Abstract
Hairy cell leukaemia (HCL) occasionally displays a monoclonal gammopathy, yet the association of HCL with paraproteinemic demyelinating neuropathy (PDN) has not been reported. We describe a HCL case complicated by PDN and high titers of monoclonal IgM against myelin associated glycoprotein (MAG). Heavy and light chains of the patient's anti-MAG monoclonal protein were consistent with those expressed by HCL cells. After treatment with cladribrine, remission of HCL strictly paralleled disappearance of the IgM monoclonal protein and of the serum anti-MAG activity, and led to PDN clinical and electrophysiological improvement. Purine analogs may represent a choice in IgM PDN associated with lymphoproliferative disorders.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Cladribine / administration & dosage*
-
Demyelinating Autoimmune Diseases, CNS / complications*
-
Demyelinating Autoimmune Diseases, CNS / drug therapy*
-
Demyelinating Autoimmune Diseases, CNS / immunology
-
Gene Expression Regulation, Leukemic / drug effects
-
Gene Expression Regulation, Leukemic / immunology
-
Humans
-
Immunoglobulin Heavy Chains / immunology
-
Immunoglobulin Light Chains / immunology
-
Immunoglobulin M / metabolism
-
Immunosuppressive Agents / administration & dosage*
-
Leukemia, Hairy Cell / complications*
-
Leukemia, Hairy Cell / drug therapy*
-
Leukemia, Hairy Cell / immunology
-
Male
-
Myelin-Associated Glycoprotein / immunology
-
Paraproteinemias / complications*
-
Paraproteinemias / drug therapy*
-
Paraproteinemias / immunology
-
Remission Induction
Substances
-
Immunoglobulin Heavy Chains
-
Immunoglobulin Light Chains
-
Immunoglobulin M
-
Immunosuppressive Agents
-
Myelin-Associated Glycoprotein
-
Cladribine